Produkty 5295-66-9

CAS 5295-66-9 występuje w naszej ofercie pod nazwami: 5Alpha-Dihydrotestosterone (2,2,4,4-D4, 98%) 95% Chemical Purity, >95% (HPLC), 5alpha-Androstan-17beta-ol-3-one-2,2,4,4-d4, 98 atom % D, min 98% Chemical Purity, 5Alpha-Androstan-17beta-ol-3-one-2,2,4,4-d4. Oferty producentów: TRC, CDN, Biosynth. Dostępne opakowania: 10mg, 1mg, 2,5mg, 0,05g, 0,01g, 25mg, 50mg.

5Alpha-Dihydrotestosterone (2,2,4,4-D4, 98%) 95% Chemical Purity, >95% (HPLC)
TRC
  • opakowanie: 10mg, 1mg, 2,5mg
  • Warianty: 3
Zobacz produkt
5alpha-Androstan-17beta-ol-3-one-2,2,4,4-d4, 98 atom % D, min 98% Chemical Purity
CDN
  • opakowanie: 0,05g, 0,01g
  • Warianty: 2
Zobacz produkt
5Alpha-Androstan-17beta-ol-3-one-2,2,4,4-d4
Biosynth
  • opakowanie: 25mg, 50mg
  • Warianty: 2
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(5S,8R,9S,10S,13S,14S,17S)-2,2,4,4-tetradeuterio-17-hydroxy-10,13-dimethyl-1,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one (CAS 5295-66-9) to związek chemiczny o wzorze sumarycznym C19H30O2 i masie molowej 294.5 g/mol. Nazwa systematyczna IUPAC: (5S,8R,9S,10S,13S,14S,17S)-2,2,4,4-tetradeuterio-17-hydroxy-10,13-dimethyl-1,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one. InChIKey: NVKAWKQGWWIWPM-FVMZMTMBSA-N.

Dane identyfikacyjne
Wzór sumarycznyC19H30O2
Masa molowa294.5 g/mol
Nazwa IUPAC(5S,8R,9S,10S,13S,14S,17S)-2,2,4,4-tetradeuterio-17-hydroxy-10,13-dimethyl-1,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one
InChIKeyNVKAWKQGWWIWPM-FVMZMTMBSA-N
SMILES[2H]C1(C[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3CC[C@H]2C(C1=O)([2H])[2H])CC[C@@H]4O)C)C)[2H]

Dane obliczone przez PubChem (NCBI)

Synonimy: 17ss-Hydroxy-5a-androstan-3-one-2,2,4,4-d4, 5a-Dihydrotestosterone (2,2,4,4-D4, 98%), 95%, 5-Dihydrotestosterone-d4, orb2299763, orb2299951, 5alpha-Dihydrotestosterone-2,2,4,4-d4, (5alpha,17beta)-17-Hydroxyandrostan-3-one-2,2,4,4-d4
Powiązane formy tego związku
(5S,8R,9S,10S,13S,14S,17R)-17-hydroxy-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one C19H30O2
(5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one C19H30O2
(5R,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one C19H30O2
(5S,9S,10S,13S,14S,17S)-16,16,17-trideuterio-17-hydroxy-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15-dodecahydrocyclopenta[a]phenanthren-3-one C19H30O2
(5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one C19H30O2
Izomery (ten sam wzór sumaryczny)
nonadeca-2,4-diynoic acid C19H30O2
dodecyl benzoate C19H30O2
4-dodecoxybenzaldehyde C19H30O2
4-dodecylbenzoic acid C19H30O2
2,4,6-tritert-butylbenzoic acid C19H30O2
methyl (6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoate C19H30O2
(3S,5S,8R,9S,10S,13S,14S)-3-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-one C19H30O2